ArticleCell death & disease2018

Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.

Dongshao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.